TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+8.32%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$349M
AUM Growth
+$349M
(-28%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-47.94%
Top 10 Holdings %
Top 10 Hldgs %
53.65%
Holding
80
New
7
Increased
8
Reduced
23
Closed
21
Top Buys
| 1 |
Henry Schein
HSIC
|
$15.2M |
| 2 |
Cigna
CI
|
$8.3M |
| 3 |
AdaptHealth
AHCO
|
$8.22M |
| 4 |
Viatris
VTRS
|
$8.22M |
| 5 |
UnitedHealth
UNH
|
$8.01M |
Top Sells
| 1 |
Hologic
HOLX
|
$20.5M |
| 2 |
Labcorp
LH
|
$20.4M |
| 3 |
Quest Diagnostics
DGX
|
$17.8M |
| 4 |
RadNet
RDNT
|
$15.5M |
| 5 |
LMNX
Luminex Corp
LMNX
|
$15.3M |
Sector Composition
| 1 | Healthcare | 87.71% |
| 2 | Consumer Staples | 5.25% |
| 3 | Consumer Discretionary | 1.6% |
| 4 | Technology | 0.37% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Medtronic
MDT
$119B
| $31M | 8.79% |
250,000
-50,000
| -17% | -$6.21M |
|
2
Rigel Pharmaceuticals
RIGL
$697M
| $27.8M | 7.87% |
6,400,000
-1,950,000
| -23% | -$8.46M |
|
|
3
Henry Schein
HSIC
$8.44B
| $23.4M | 6.62% |
315,000
+205,000
| +186% | +$15.2M |
|
4
Pacira BioSciences
PCRX
$1.2B
| $21.8M | 6.19% |
360,000
-190,000
| -35% | -$11.5M |
|
5
Turning Point Brands
TPB
$1.79B
| $18.3M | 5.19% |
400,000
| – | – |
|
|
PDCO
6
DELISTED
Patterson Companies, Inc.
PDCO
| $14.4M | 4.09% |
475,000
-295,000
| -38% | -$8.96M |
|
|
VRAY
7
DELISTED
ViewRay, Inc.
VRAY
| $13.2M | 3.74% |
2,000,000
-450,000
| -18% | -$2.97M |
|
8
Integer Holdings
ITGR
$3.78B
| $12.7M | 3.6% |
135,000
+5,200
| +4% | +$490K |
|
9
Lantheus
LNTH
$3.73B
| $12.4M | 3.52% |
450,000
-475,000
| -51% | -$13.1M |
|
|
10
UnitedHealth
UNH
$281B
| $12M | 3.4% |
30,000
+20,000
| +200% | +$8.01M |
|
11
AtriCure
ATRC
$1.84B
| $11.9M | 3.37% |
150,000
-50,000
| -25% | -$3.97M |
|
|
12
Viatris
VTRS
$12.3B
| $11.8M | 3.34% |
825,000
+575,000
| +230% | +$8.22M |
|
13
United Therapeutics
UTHR
$13.8B
| $11.1M | 3.15% |
62,000
-38,000
| -38% | -$6.82M |
|
|
STRM
14
DELISTED
Streamline Health Solutions
STRM
| $8.73M | 2.47% |
4,930,882
| – | – |
|
15
Bioventus
BVS
$495M
| $8.36M | 2.37% |
475,000
-200,000
| -30% | -$3.52M |
|
16
CVS Health
CVS
$92.8B
| $8.34M | 2.36% |
100,000
-125,000
| -56% | -$10.4M |
|
|
MDRX
17
DELISTED
Veradigm Inc. Common Stock
MDRX
| $8.33M | 2.36% |
450,000
-425,000
| -49% | -$7.87M |
|
|
MSON
18
DELISTED
Misonix Inc
MSON
| $8.32M | 2.36% |
375,000
+25,000
| +7% | +$555K |
|
|
19
Cigna
CI
$80.3B
| $8.3M | 2.35% |
+35,000
| New | +$8.3M |
|
|
20
AdaptHealth
AHCO
$1.28B
| $8.22M | 2.33% |
+300,000
| New | +$8.22M |
|
21
AngioDynamics
ANGO
$417M
| $8.14M | 2.31% |
300,000
-25,000
| -8% | -$678K |
|
22
SI-BONE Inc
SIBN
$719M
| $8.03M | 2.27% |
255,000
-20,000
| -7% | -$629K |
|
|
23
RadNet
RDNT
$5.52B
| $7.58M | 2.15% |
225,000
-460,000
| -67% | -$15.5M |
|
24
ICU Medical
ICUI
$3.15B
| $7M | 1.98% |
34,000
-36,000
| -51% | -$7.41M |
|
25
Phreesia
PHR
$1.88B
| $6.85M | 1.94% |
+111,800
| New | +$6.85M |
|